NO743900L - - Google Patents
Info
- Publication number
- NO743900L NO743900L NO743900A NO743900A NO743900L NO 743900 L NO743900 L NO 743900L NO 743900 A NO743900 A NO 743900A NO 743900 A NO743900 A NO 743900A NO 743900 L NO743900 L NO 743900L
- Authority
- NO
- Norway
- Prior art keywords
- stated
- picolylamine
- amine
- anhydride
- mol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 claims description 2
- -1 N-substituted dipropylacetamides Chemical class 0.000 claims description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 150000007529 inorganic bases Chemical class 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 7
- 150000008064 anhydrides Chemical class 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical class CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 241000700159 Rattus Species 0.000 description 10
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 9
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 6
- 229960003529 diazepam Drugs 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 229960005152 pentetrazol Drugs 0.000 description 5
- 229960001412 pentobarbital Drugs 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000000147 hypnotic effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- PITHYUDHKJKJNQ-UHFFFAOYSA-N 2-propylpentanoyl chloride Chemical compound CCCC(C(Cl)=O)CCC PITHYUDHKJKJNQ-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- UQFAHDJERLHPCA-UHFFFAOYSA-N 2-propyl-n-(pyridin-2-ylmethyl)pentanamide Chemical compound CCCC(CCC)C(=O)NCC1=CC=CC=N1 UQFAHDJERLHPCA-UHFFFAOYSA-N 0.000 description 2
- IXSFUFRHFRIOGN-UHFFFAOYSA-N 2-propyl-n-(pyridin-3-ylmethyl)pentanamide Chemical compound CCCC(CCC)C(=O)NCC1=CC=CN=C1 IXSFUFRHFRIOGN-UHFFFAOYSA-N 0.000 description 2
- ORRZGUBHBVWWOP-UHFFFAOYSA-N 4-ethyl-4-methylpiperidine-2,6-dione Chemical compound CCC1(C)CC(=O)NC(=O)C1 ORRZGUBHBVWWOP-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229940125717 barbiturate Drugs 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- SPRFYEQSQCTBNY-UHFFFAOYSA-N 2-propyl-n-(pyridin-4-ylmethyl)pentanamide Chemical compound CCCC(CCC)C(=O)NCC1=CC=NC=C1 SPRFYEQSQCTBNY-UHFFFAOYSA-N 0.000 description 1
- GYIUDLLQLVWKPP-UHFFFAOYSA-N 2-propylpentanoyl 2-propylpentanoate Chemical compound CCCC(CCC)C(=O)OC(=O)C(CCC)CCC GYIUDLLQLVWKPP-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 229960000750 bemegride Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003179 convulsant agent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES420074A ES420074A1 (es) | 1973-10-30 | 1973-10-30 | Un metodo para la produccion industrial de dipropilacetami-das n-sustituidas. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO743900L true NO743900L (xx) | 1975-05-26 |
Family
ID=8465304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743900A NO743900L (xx) | 1973-10-30 | 1974-10-29 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3951995A (xx) |
| JP (1) | JPS5093977A (xx) |
| AU (1) | AU7487874A (xx) |
| BE (1) | BE821639A (xx) |
| DE (1) | DE2449846A1 (xx) |
| DK (1) | DK563774A (xx) |
| ES (1) | ES420074A1 (xx) |
| FI (1) | FI305274A (xx) |
| FR (1) | FR2248839B1 (xx) |
| GB (1) | GB1434698A (xx) |
| HU (1) | HU168269B (xx) |
| IL (1) | IL45904A0 (xx) |
| IN (1) | IN141278B (xx) |
| NL (1) | NL7414090A (xx) |
| NO (1) | NO743900L (xx) |
| RO (1) | RO70439A (xx) |
| SE (1) | SE7413213L (xx) |
| ZA (1) | ZA746759B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES479959A1 (es) * | 1979-04-26 | 1979-12-01 | Made Labor Sa | Un procedimiento para la produccion industrial de 1,2-diaci-lamino-1,2-di(4-piridil)etanos. |
| MA20552A1 (fr) * | 1985-10-11 | 1986-07-01 | Pan Medica Sa | Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1229064B (de) * | 1962-11-03 | 1966-11-24 | Basf Ag | Verfahren zur kontinuierlichen Herstellung von niedrigmolekularen Carbonsaeureamiden |
| US3367940A (en) * | 1963-01-02 | 1968-02-06 | Chevron Res | Beta-picolinamide derivatives |
| US3528987A (en) * | 1964-07-31 | 1970-09-15 | Geigy Chem Corp | N-(substituted pyridyl)rinolamides and -linolenamides |
-
1973
- 1973-10-30 ES ES420074A patent/ES420074A1/es not_active Expired
-
1974
- 1974-08-30 IN IN1744/CAL/1974A patent/IN141278B/en unknown
- 1974-10-18 FI FI3052/74A patent/FI305274A/fi unknown
- 1974-10-19 DE DE19742449846 patent/DE2449846A1/de active Pending
- 1974-10-21 SE SE7413213A patent/SE7413213L/xx unknown
- 1974-10-22 IL IL45904A patent/IL45904A0/xx unknown
- 1974-10-23 GB GB4591174A patent/GB1434698A/en not_active Expired
- 1974-10-24 ZA ZA00746759A patent/ZA746759B/xx unknown
- 1974-10-24 US US05/517,550 patent/US3951995A/en not_active Expired - Lifetime
- 1974-10-29 FR FR7436166A patent/FR2248839B1/fr not_active Expired
- 1974-10-29 NL NL7414090A patent/NL7414090A/xx unknown
- 1974-10-29 NO NO743900A patent/NO743900L/no unknown
- 1974-10-29 RO RO7480362A patent/RO70439A/ro unknown
- 1974-10-29 BE BE150020A patent/BE821639A/xx unknown
- 1974-10-29 JP JP49124034A patent/JPS5093977A/ja active Pending
- 1974-10-29 DK DK563774A patent/DK563774A/da unknown
- 1974-10-30 HU HUMA2612A patent/HU168269B/hu unknown
- 1974-10-30 AU AU74878/74A patent/AU7487874A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3951995A (en) | 1976-04-20 |
| IL45904A0 (en) | 1974-12-31 |
| NL7414090A (nl) | 1975-05-02 |
| RO70439A (ro) | 1981-06-30 |
| GB1434698A (en) | 1976-05-05 |
| FI305274A (xx) | 1975-05-01 |
| JPS5093977A (xx) | 1975-07-26 |
| BE821639A (fr) | 1975-04-29 |
| DE2449846A1 (de) | 1975-05-07 |
| FR2248839A1 (xx) | 1975-05-23 |
| FR2248839B1 (xx) | 1977-05-20 |
| ZA746759B (en) | 1975-10-29 |
| IN141278B (xx) | 1977-02-12 |
| AU7487874A (en) | 1976-05-06 |
| HU168269B (xx) | 1976-03-28 |
| SE7413213L (xx) | 1975-05-02 |
| DK563774A (xx) | 1975-06-23 |
| ES420074A1 (es) | 1976-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2086542C1 (ru) | Серосодержащие производные имидазола, способ их получения, новые промежуточные соединения и фармацевтическая композиция | |
| NO173016B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-laktamderivater | |
| JPH0349899B2 (xx) | ||
| DK141069B (da) | Analogifremgangsmåde til fremstilling af 1,5,10,10a-tetrahydrothiazolo (3,4-b)isoquinolinderivater eller syreadditionssalte deraf. | |
| DK168010B1 (da) | Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse | |
| SU593669A3 (ru) | Способ получени тиено (3,2-с) пиридина | |
| US5464860A (en) | N(pyrazol-3-yl) benzamides and pharmaceutical compositions | |
| FI78084C (fi) | Foerfarande foer framstaellning av nya, terapeutiskt verksamma bensopyranderivat. | |
| SU453830A3 (ru) | Способ получения соответственно замещенного фенацетилгуанидина | |
| NO743900L (xx) | ||
| HU181742B (en) | Process for producing new azetidinone derivatives | |
| US2519530A (en) | Biotin aliphatic amides and method for their preparation | |
| NO157782B (no) | Analogifremgangsmte for fremstilling av terapeutisk aktive kondenserte as-triazinderivater med et pyridoringsystem hvor de to ringsystemer har et felles n-atom. | |
| DK141531B (da) | Analogifremgangsmåde til fremstilling af 1-metyl-9,10-dihydro-d-lysergsyreallylamid eller syreadditionssalte deraf. | |
| US2532547A (en) | Z-aminoalkyl-glyoxaline derivatives | |
| NO832810L (no) | 1,3-dioksolo(4,5-g)-kinoliner og fremgangsmaate for deres fremstilling. | |
| US3509165A (en) | Process for preparing pyridinium betaines and derivatives | |
| NO164352B (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive, antivirale, substituerte isoksazolderivater. | |
| NO134112B (xx) | ||
| NO165419B (no) | Innretning for laasing og frigjoering av gjenstander beregnet for offentlig bruk, saasom bagasjetraller. | |
| SU922107A1 (ru) | Способ получени R,S-2,3,5,6-тетрагидро-6-фенилимидазо /2,1- @ / тиазола /тетрамизола/ | |
| SU470957A3 (ru) | Способ получени производных 4-аминопирролин-3-она-2 или их солей | |
| US4055592A (en) | N-(Sulfo-lower alkyl) amides of (3-trifluoromethylphenoxy) (4-chlorophenyl)acetic acid | |
| SU528871A3 (ru) | Способ получени производных 2-(1н) -хиназолинона | |
| US2660582A (en) | Quaternary nicotinic acid amide derivatives and production thereof |